Ophthalmology

The Biology of a Leak: How DME is Diagnosed

At a Glance

Diabetic macular edema is diagnosed by combining an eye exam with retinal imaging: OCT measures swelling and shows whether it reaches the center, fluorescein angiography maps leakage, and OCTA evaluates blood flow and possible macular ischemia.

To understand Diabetic Macular Edema (DME), it helps to distinguish it from the broader condition called Diabetic Retinopathy (DR). While they are related, they are not the same thing. Think of Diabetic Retinopathy as the overall health of the “wallpaper” (the retina) lining the back of your eye. DME is a specific complication where a small, critical area of that wallpaper—the macula—becomes waterlogged and swollen ^[1]^[2]. You can have signs of retinopathy throughout your eye without having DME, but when DME develops, it directly threatens your central, “straight-ahead” vision ^[3].

The Biology of a Leak

The retina requires a stable environment to function. This is maintained by the blood-retinal barrier (BRB), a tightly sealed system of blood vessels that controls what enters the retinal tissue ^[4]. Chronic high blood sugar (hyperglycemia) acts like a slow-moving toxin that breaks this seal through several steps:

Oxidative Stress and Inflammation: High sugar levels create “oxidative stress,” which triggers the release of inflammatory chemicals like TNF-α and VEGF (vascular endothelial growth factor) ^[5]^[6].
Pericyte Loss: Pericytes are specialized “wrap-around” cells that provide structural support to your smallest blood vessels (capillaries). In diabetes, these cells are among the first to die, leaving the vessel walls weak and prone to bulging ^[7]^[8].
Broken Seals: The inflammatory chemicals (especially VEGF) cause the “tight junctions”—the molecular glue holding vessel cells together—to pull apart ^[9].
Leakage and Hard Exudates: Once the barrier is broken, fluid, proteins, and fats leak out. Over time, as this fluid is reabsorbed and reorganized by the body, it leaves behind lipid- and protein-rich deposits called hard exudates, which look like small yellow spots on an eye exam ^[10]^[11].

How Doctors “See” the Edema

Because you can’t feel the swelling inside your eye, doctors use a combination of high-tech imaging to map the damage. Not all of these tests are used at every visit; your doctor will order them selectively.

Optical Coherence Tomography (OCT)

This is the standard, everyday tool for monitoring DME ^[12]. It uses light waves to take a cross-sectional, 3D picture of your retina, much like an ultrasound but with light.

What it finds: It measures exactly how thick the macula is.
Why it matters: Doctors use OCT to determine if the swelling is center-involving (affecting the very middle of your vision) or non-center-involving (off to the side) ^[13]^[12]. This distinction helps determine whether you need treatment immediately or can be safely monitored ^[14].

Fluorescein Angiography (FA)

While OCT shows the structure of the swelling, FA shows the function of the blood vessels. A yellow dye (fluorescein) is injected into a vein in your arm, and a camera takes pictures as the dye travels through your eye ^[15].

What it finds: It identifies microaneurysms (tiny pouches in weakened vessels) and shows exactly where the dye is leaking out ^[16]^[17].
Why it matters: It helps your doctor decide if the leakage is coming from a few specific points or from a broader network, which can guide choices like laser therapy ^[17].

OCT Angiography (OCTA)

This is a newer, non-invasive test that maps blood flow without using any dye ^[18].

What it finds: It can detect areas of reduced blood flow or macular ischemia, where tiny capillaries are no longer carrying blood efficiently ^[19]. However, OCTA images can be affected by motion and processing artifacts.
Why it matters: While it cannot by itself prove that vessels have permanently “died,” it gives your doctor clues about blood flow that help set realistic expectations for visual recovery ^[20].

Clinically Significant Macular Edema (CSME)

You may occasionally hear or read the historical term Clinically Significant Macular Edema (CSME) ^[21]. This is a clinical classification based on what a doctor physically sees during a standard eye exam, which historically helped guide laser treatment ^[22]^[23]. Today, modern decisions are largely guided by OCT scans and visual acuity rather than just the physical exam, so having CSME does not mean you face inevitable or permanent vision loss.

Common questions in this guide

How does an OCT scan show whether DME is center-involving?

OCT creates a cross-sectional image of the retina and measures the thickness of the macula. It shows whether swelling reaches the center of the macula, a distinction that helps your doctor decide whether treatment is needed promptly or monitoring may be appropriate.

What does fluorescein angiography show in diabetic macular edema?

Fluorescein angiography uses dye injected into a vein in your arm to show blood vessels as the dye travels through the eye. It can reveal tiny vessel pouches called microaneurysms and pinpoint leaking areas, including whether leakage is more focal or widespread.

What can OCT angiography tell me about DME?

OCT angiography is a noninvasive test that maps blood flow without injected dye. It can show reduced flow and clues to macular ischemia, but motion and image-processing artifacts can affect the results, and the test alone cannot prove that vessels have permanently stopped functioning.

Does clinically significant macular edema mean I will permanently lose vision?

No. Clinically significant macular edema is a historical classification based on findings during an eye examination, and it does not mean permanent vision loss is inevitable. Current decisions also consider OCT findings and visual acuity.

What are hard exudates and microaneurysms in diabetic retinopathy?

Microaneurysms are tiny pouches in weakened retinal blood vessels that may leak. Hard exudates are yellow deposits of fats and proteins left behind as leaked fluid is reabsorbed and reorganized.

Can diabetic macular edema make straight lines look wavy?

Swelling in the macula can affect central, straight-ahead vision, so lines may look wavy or distorted in the center. Report this change to your eye doctor, who can evaluate it with a dilated examination and retinal imaging.

Get notified when new evidence is published on diabetic macular edema.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (23)

1
Interleaved Optical Coherence Tomography: Clinical and Laboratory Biomarkers in Patients with Diabetic Macular Edema.
Suciu CI, Suciu VI, Cuţaş A, Nicoară SD
Journal of personalized medicine 2022; (12(5)) doi:10.3390/jpm12050765.
PMID: 35629188
2
Laser Treatment Modalities for Diabetic Retinopathy.
Pande GS, Tidake P
Cureus 2022; (14(10)):e30024 doi:10.7759/cureus.30024.
PMID: 36348830
3
Retinal layer location of increased retinal thickness in eyes with subclinical and clinical macular edema in diabetes type 2.
Bandello F, Tejerina AN, Vujosevic S, et al.
Ophthalmic research 2015; (54(3)):112-7 doi:10.1159/000438792.
PMID: 26315448
4
The Treatment of Diabetic Retinal Edema with Intravitreal Steroids: How and When.
Salvetat ML, Pellegrini F, Spadea L, et al.
Journal of clinical medicine 2024; (13(5)) doi:10.3390/jcm13051327.
PMID: 38592149
5
Melatonin maintains inner blood-retinal barrier via inhibition of p38/TXNIP/NF-κB pathway in diabetic retinopathy.
Tang L, Zhang C, Yang Q, et al.
Journal of cellular physiology 2021; (236(8)):5848-5864 doi:10.1002/jcp.30269.
PMID: 33432588
6
Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy.
Tang L, Xu GT, Zhang JF
Neural regeneration research 2023; (18(5)):976-982 doi:10.4103/1673-5374.355743.
PMID: 36254977
7
Targeting Angiopoietin in Retinal Vascular Diseases: A Literature Review and Summary of Clinical Trials Involving Faricimab.
Khan M, Aziz AA, Shafi NA, et al.
Cells 2020; (9(8)) doi:10.3390/cells9081869.
PMID: 32785136
8
Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.
Das A, McGuire PG, Rangasamy S
Ophthalmology 2015; (122(7)):1375-94.
PMID: 25935789
9
PHD2 attenuates high-glucose-induced blood retinal barrier breakdown in human retinal microvascular endothelial cells by regulating the Hif-1α/VEGF pathway.
Li J, Lu X, Wei L, et al.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2022; (71(1)):69-79 doi:10.1007/s00011-021-01518-2.
PMID: 34773469
10
Mechanisms of macular edema: Beyond the surface.
Daruich A, Matet A, Moulin A, et al.
Progress in retinal and eye research 2018; (63()):20-68 doi:10.1016/j.preteyeres.2017.10.006.
PMID: 29126927
11
Current Treatments for Diabetic Macular Edema.
Tatsumi T
International journal of molecular sciences 2023; (24(11)) doi:10.3390/ijms24119591.
PMID: 37298544
12
Pathological Neurovascular Unit Mapping onto Multimodal Imaging in Diabetic Macular Edema.
Murakami T, Ishihara K, Terada N, et al.
Medicina (Kaunas, Lithuania) 2023; (59(5)) doi:10.3390/medicina59050896.
PMID: 37241128
13
Real-world Outcomes among Eyes with Center-Involving Diabetic Macular Edema and Good Visual Acuity.
Zafar S, Smith K, Boland MV, et al.
Current eye research 2020; (45(7)):879-887 doi:10.1080/02713683.2019.1703007.
PMID: 31829753
14
Diabetic Macular Edema: Traditional and Novel Treatment
Tomić M, Vrabec R, Poljičanin T, et al.
Acta clinica Croatica 2017; (56(1)):124-132 doi:10.20471/acc.2017.56.01.18.
PMID: 29120156
15
Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema.
Markan A, Agarwal A, Arora A, et al.
Therapeutic advances in ophthalmology 2020; (12()):2515841420950513 doi:10.1177/2515841420950513.
PMID: 32954207
16
Quantitative Ultra-Widefield Angiographic Features and Associations with Diabetic Macular Edema.
Jiang AC, Srivastava SK, Hu M, et al.
Ophthalmology. Retina 2020; (4(1)):49-56 doi:10.1016/j.oret.2019.08.008.
PMID: 31690541
17
Clinical application of optical coherence tomography angiography in diabetic macular edema.
Lv M, Li T, Li Y
African health sciences 2023; (23(2)):484-489 doi:10.4314/ahs.v23i2.56.
PMID: 38223604
18
The Evaluation of Diabetic Macular Ischemia Using Optical Coherence Tomography Angiography.
Bradley PD, Sim DA, Keane PA, et al.
Investigative ophthalmology & visual science 2016; (57(2)):626-31 doi:10.1167/iovs.15-18034.
PMID: 26903223
19
COMPARING FUNDUS FLUORESCEIN ANGIOGRAPHY AND SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN THE EVALUATION OF DIABETIC MACULAR PERFUSION.
La Mantia A, Kurt RA, Mejor S, et al.
Retina (Philadelphia, Pa.) 2019; (39(5)):926-937 doi:10.1097/IAE.0000000000002045.
PMID: 29346244
20
A Swept source optical coherence tomography angiography study: Imaging artifacts and comparison of non-perfusion areas with fluorescein angiography in diabetic macular edema.
Podkowinski D, Beka S, Mursch-Edlmayr AS, et al.
PloS one 2021; (16(4)):e0249918 doi:10.1371/journal.pone.0249918.
PMID: 33831123
21
The Early Treatment Diabetic Retinopathy Study historical review and relevance to today's management of diabetic macular edema.
Relhan N, Flynn HW
Current opinion in ophthalmology 2017; (28(3)):205-212 doi:10.1097/ICU.0000000000000362.
PMID: 28151747
22
A Revised Approach for the Detection of Sight-Threatening Diabetic Macular Edema.
Litvin TV, Bresnick GH, Cuadros JA, et al.
JAMA ophthalmology 2017; (135(1)):62-68 doi:10.1001/jamaophthalmol.2016.4772.
PMID: 27930756
23
Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.
Virgili G, Menchini F, Casazza G, et al.
The Cochrane database of systematic reviews 2015; (1()):CD008081 doi:10.1002/14651858.CD008081.pub3.
PMID: 25564068

This page explains DME biology and diagnostic imaging for informational purposes only and does not constitute medical advice. Ask your eye doctor to interpret your OCT or angiography results and discuss care for your situation.

Guide Contents